Necitumumab: a new option for first-line treatment of squamous cell lung cancer-Reference-Cited by-同舟云学术

Necitumumab: a new option for first-line treatment of squamous cell lung cancer

Published:2018-07-31 Issue:8 Volume:14 Page:765-772
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Jiménez Aguilar Elizabeth¹²,Zugazagoitia Fraile Jon¹²,Paz-Ares Rodríguez Luis¹²³

Affiliation:

1. Medical Oncology Department, Hospital Universitario 12 de Octubre and Instituto de Investigación i+12, Madrid, Spain

2. Lung Cancer Group, Clinical Research Program, CNIO (Centro Nacional de Investigaciones Oncológicas) and Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain

3. Medical Oncology department, Complutense University, Madrid, Spain

Funder

Instituto de Salud Carlos III

ISCIII

CIBERONC

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2018.1498839

Reference63 articles.

1. Non–Small Cell Lung Cancer

2. American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003

3. Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging trends in immunotoxin targeting cancer stem cells;Toxicology in Vitro;2022-09

2. E47 upregulates ΔNp63α to promote growth of squamous cell carcinoma;Cell Death & Disease;2021-04

3. A Systematic Analysis of Dysregulated Long Non-Coding RNAs/microRNAs/mRNAs in Lung Squamous Cell Carcinoma;The American Journal of the Medical Sciences;2020-12

4. Effects of adding necitumumab to first-line chemotherapy in patients with stage IV non-small-cell lung cancer: Meta-analysis;Journal of Oncology Pharmacy Practice;2019-12-10